TARA
Protara Therapeutics·NASDAQ
--
--(--)
--
--(--)
TARA Filings
Filing Date
Form Description
Form Type
2025-12-15
Form 8-K - Current report
Key Events
2025-12-15 · Key Events
Form 8-K - Current report
2025-12-09
Form 424B7 - Prospectus [Rule 424(b)(7)]
2025-12-09 ·
Form 424B7 - Prospectus [Rule 424(b)(7)]
2025-12-08
Form 8-K - Current report
Key Events
2025-12-08 · Key Events
Form 8-K - Current report
2025-12-05
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-05 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-04
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-04 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-03
Form 8-K - Current report
Key Events
2025-12-03 · Key Events
Form 8-K - Current report
2025-11-19
Form 8-K - Current report
Key Events
2025-11-19 · Key Events
Form 8-K - Current report
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-10
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-10 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-10
Form 8-K - Current report
Key Events
2025-11-10 · Key Events
Form 8-K - Current report
